Analyst consensus rating
NRX Pharmaceuticals Analyst Rating: Strong Buy
NRXP is rated Strong Buy by 4 analysts with a $38.25 target. As of 2026-08-31.
Direct answer
NRX Pharmaceuticals's consensus rating is Strong Buy.
4 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $38.25.
Forecast evidence checked August 31, 2026.
Get free NRX Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $3.55
- Average price target
- $38.25
- High price target
- $49.00
- Low price target
- $10.00
- Low target gap
- +181.7%
- Target upside
- +977.5%
- High target gap
- +1,280.3%
- Target range width
- 1,098.6%
- Consensus rating
- Strong Buy
- Analysts
- 4
- Evidence date
- August 31, 2026
- Valid through
- September 7, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for NRX Pharmaceuticals?
NRX Pharmaceuticals has a verified Strong Buy consensus. The same dataset has an average price target of $38.25.
How far are NRX Pharmaceuticals's low and high targets from the recorded price?
The low target implies +181.7%, while the high target implies +1,280.3%.
How many analysts are included in NRX Pharmaceuticals's consensus?
The verified consensus includes 4 analysts.
How is NRX Pharmaceuticals's target upside or downside calculated?
The average target of $38.25 is divided by the recorded price of $3.55, then one is subtracted to produce +977.5%. This does not guarantee a future return.
When was NRX Pharmaceuticals's analyst forecast verified?
The data was verified on 2026-08-31. The dataset is valid through 2026-09-07.